These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 19056315)

  • 1. Tumour vascularisation: a druggable target.
    Bishop-Bailey D
    Curr Opin Pharmacol; 2009 Apr; 9(2):96-101. PubMed ID: 19056315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour vasculature as a target for anticancer therapy.
    Eatock MM; Schätzlein A; Kaye SB
    Cancer Treat Rev; 2000 Jun; 26(3):191-204. PubMed ID: 10814561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis.
    Noguera-Troise I; Daly C; Papadopoulos NJ; Coetzee S; Boland P; Gale NW; Lin HC; Yancopoulos GD; Thurston G
    Nature; 2006 Dec; 444(7122):1032-7. PubMed ID: 17183313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour-associated angiogenesis in human colorectal cancer.
    Rmali KA; Puntis MC; Jiang WG
    Colorectal Dis; 2007 Jan; 9(1):3-14. PubMed ID: 17181841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The VEGF/Rho GTPase signalling pathway: a promising target for anti-angiogenic/anti-invasion therapy.
    van der Meel R; Symons MH; Kudernatsch R; Kok RJ; Schiffelers RM; Storm G; Gallagher WM; Byrne AT
    Drug Discov Today; 2011 Mar; 16(5-6):219-28. PubMed ID: 21262381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain angiogenesis in developmental and pathological processes: therapeutic aspects of vascular endothelial growth factor.
    Shibuya M
    FEBS J; 2009 Sep; 276(17):4636-43. PubMed ID: 19664071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of angiogenesis inhibitors in tumour treatment.
    Fayette J; Soria JC; Armand JP
    Eur J Cancer; 2005 May; 41(8):1109-16. PubMed ID: 15911233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of angiogenesis in human neoplasms: current prognostic and therapeutic implications.
    Fontanini G; Del Mastro L; Bevilacqua G
    Forum (Genova); 1998; 8(2):128-42. PubMed ID: 9666050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tumour angiogenesis and therapy directed at the neovasculature].
    Eikesdal HP; Dahl O; Straume O; Akslen LA
    Tidsskr Nor Laegeforen; 2004 Aug; 124(15):1919-22. PubMed ID: 15306859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current concerns and challenges regarding tailored anti-angiogenic therapy in cancer.
    Roukos DH; Tzakos A; Zografos G
    Expert Rev Anticancer Ther; 2009 Oct; 9(10):1413-6. PubMed ID: 19828000
    [No Abstract]   [Full Text] [Related]  

  • 11. Selective targeting of the tumour vasculature.
    Chan LS; Daruwalla J; Christophi C
    ANZ J Surg; 2008 Nov; 78(11):955-67. PubMed ID: 18959693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting tumor angiogenesis.
    Gaur P; Bose D; Samuel S; Ellis LM
    Semin Oncol; 2009 Apr; 36(2 Suppl 1):S12-9. PubMed ID: 19393831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Angiogenesis inhibitors in advanced cancer. Many current clinical trials show promising results].
    Christofferson R
    Lakartidningen; 1998 May; 95(20):2349-54. PubMed ID: 9630803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are tumours angiogenesis-dependent?
    Verheul HM; Voest EE; Schlingemann RO
    J Pathol; 2004 Jan; 202(1):5-13. PubMed ID: 14694516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VEGF inhibition: insights from preclinical and clinical studies.
    Crawford Y; Ferrara N
    Cell Tissue Res; 2009 Jan; 335(1):261-9. PubMed ID: 18766380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mathematical modelling of flow through vascular networks: implications for tumour-induced angiogenesis and chemotherapy strategies.
    McDougall SR; Anderson AR; Chaplain MA; Sherratt JA
    Bull Math Biol; 2002 Jul; 64(4):673-702. PubMed ID: 12216417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondria as targets in angiogenesis inhibition.
    Park D; Dilda PJ
    Mol Aspects Med; 2010 Feb; 31(1):113-31. PubMed ID: 19995570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-angiogenic therapy against gastrointestinal tract cancers.
    Iwasaki J; Nihira S
    Jpn J Clin Oncol; 2009 Sep; 39(9):543-51. PubMed ID: 19531544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-Dll4 therapy: can we block tumour growth by increasing angiogenesis?
    Sainson RC; Harris AL
    Trends Mol Med; 2007 Sep; 13(9):389-95. PubMed ID: 17822956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer angiogenesis: targeting the heel of Achilles.
    Dass CR; Choong PF
    J Drug Target; 2008 Jul; 16(6):449-54. PubMed ID: 18604657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.